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Background:While most unintended pregnancies occur because couples do not use contraception, contraceptive failure is also an important
underlying cause. However, few recent studies outside of the United States have estimated contraceptive failure rates, and most such studies
have been restricted to married women, to a limited number of countries and to 12-month failure rate estimates.
Methods: Using self-reported data from 43 countries with Demographic and Health Survey data, we estimated typical-use contraceptive
failure rates for seven contraceptive methods at 12, 24 and 36 months of use. We provide a median estimate for each method across 43
countries overall, in seven subregions and in individual countries. We assess differences by various demographic and socioeconomic
characteristics. Estimates are not corrected for potential errors in retrospective reporting contraceptive use or potential underreporting of
abortion, which may vary by country and subgroups within countries.
Results: Across all included countries, reported 12-month typical-use failure rates were lowest for users of longer-acting methods such as
implants (0.6 failures per 100 episodes of use), intrauterine devices (1.4) and injectables (1.7); intermediate for users of short-term resupply
methods such as oral contraceptive pills (5.5) and male condoms (5.4); and highest for users of traditional methods such as withdrawal (13.4)
or periodic abstinence (13.9), a group largely using calendar rhythm.
Conclusions: Our findings help us to highlight those methods, subregions and population groups that may be in need of particular attention
for improvements in policies and programs to address higher contraceptive failure rates.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd//).Keywords: Contraception; Failure rates; Unintended pregnancy; International; Life tables1. Introduction
In the developingworld, 74million unintended pregnancies
occur annually, and 30% of these are due to contraceptive
failure among women using traditional or modern contracep-
tive methods [1], including both method-related failures
(i.e., failure of a method to work as expected) and user-related
failures (i.e., failure stemming from incorrect or inconsistent
use of a method). Unintended pregnancies can have many
undesirable consequences, including unwanted childbearing,⁎ Corresponding author.
E-mail address: cpolis@guttmacher.org (C.B. Polis).
http://dx.doi.org/10.1016/j.contraception.2016.03.011
0010-7824/© 2016 The Authors. Published by Elsevier Inc. This is an open a
org/licenses/by-nc-nd//).recourse to (potentially unsafe) abortion and maternal and/or
newborn morbidity and mortality [2–4]. Measuring typical-
use contraceptive failure rates among a cross-section of users
(as opposed to failure rates from clinical studies) is critical to
informing improvements in provision of contraceptive
information, supplies and services, which can assist women
and couples to use contraception correctly and consistently.
Few recent studies outside of the United States and France
have estimated contraceptive failure rates. Studies estimating
contraceptive failure rates using Demographic and Health
Survey (DHS) data [5–8] have generally restricted analysis
to a limited number of countries or particular subgroups
(e.g., married women), and most have not provided estimates
of failure rates beyond 12 months of use.ccess article under the CC BY-NC-ND license (http://creativecommons.
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typical-use contraceptive failure rates using DHS data from
43 countries with the necessary data. Using single-decrement
life tables, we estimated contraceptive failure rates at 12, 24
and 36 months for seven contraceptive methods, including
five modern methods [implants, intrauterine devices (IUDs),
injectables, oral contraceptive pills and male condoms] and
two traditional methods [withdrawal and periodic abstinence
(largely comprised of users of the calendar rhythm method1)].
We provided detailed contraceptive failure rate estimates by
method and duration for each of 43 countries, as pooled
regional estimates for each of seven subregions and as overall
median estimates across 43 included countries. We also
estimated contraceptive failure rates for various demographic
and socioeconomic subpopulations.
The complete report and accompanying tables can be
found at http://www.guttmacher.org/report/contraceptive-
failure-rates-in-developing-world (available after March 24,
2016). This summary provides a brief overview of the
methods, analysis and key findings; readers are encouraged
to access the full report for greater detail.2. Methods
2.1. DHS surveys selected for inclusion
We used information from 43 DHS surveys, including ten
countries in Eastern Africa, five in Western Africa, six in
Northern Africa and Western Asia, five in Eastern Europe and
Central Asia, five in Southern Asia, four in Southeastern Asia
and eight in Latin America and the Caribbean (LAC). The
countries cover a substantial proportion of the population in
EasternAfrica,WesternAfrica, SouthernAsia andSoutheastern
Asia (81%, 69%, 92% and 73%, respectively [9]); data are less
representative in other subregions. We used the most recent
survey (as of June 2014) in each country that included a
reproductive calendar containing information on reasons for
contraceptive discontinuation.2 Applying the reproductive
calendar involves asking female survey respondents to
retrospectively report on their contraceptive use for the last
5 years before the interview and reasons for discontinuation.
2.2. Analytic methods
We calculated self-reported typical-use failure rates for all
users of each contraceptive method3 using single-decrement1 Where possible, women who report using fertility awareness methods
(such as the Standard Days method or the TwoDay method) were classified as
“Other modern method” users. In some cases, however, the category of periodic
abstinence users (and their failure rates) may include somewomen using fertility
awareness methods who were not identified as such through the survey.
2 In some countries, the most recent survey did not collect the
reproductive calendar or did not include the information on reasons for
discontinuation in the calendar necessary for contraceptive failure. Details
are available in the full report.
3 In seven DHS surveys that included only ever-married women, the
sample does not include any unmarried contraceptive users.life tables. In this calculation, the unit of analysis is an episode
of contraceptive use, which begins at the point in the
reproductive calendar when a woman reports initiating use
of a contraceptive method and ends when she reports
discontinuing that method. A single woman could contribute
multiple episodes, if she stopped and started using contracep-
tion several times over the last 5 years, or no episodes if she
did not use any method during that period. Estimates are not
adjusted for potential errors in retrospective reporting of
contraceptive use or potential underreporting of abortion,
which may vary by country and subgroups within countries
[10]. The period of observation for calculating contraceptive
failure rates is months 3–62 prior to the DHS survey.4 We
used individual-level sampling weights to produce nationally
representative results within each country. Failure rates are not
presented for methods with less than 125 episodes of
contraceptive use in month 1 of the life table. Ninety-five
percent confidence intervals (95% CIs) were calculated with a
jackknife approach.
We pooled data across countries (weighted equally) within
the same subregion; these should be interpreted as average
method-specific rates across the included countries. We
estimated overall contraceptive failure rates across 43 included
countries in two ways: (1) by calculating a median failure rate
bymethod and (2) by calculating a pooled all-country estimate
across all 43 countries. In describing overall failure rates, we
focus largely on median values to make our estimates more
easily comparable to previous analyses [5], but we assessed
differences by various demographic and socioeconomic
characteristics using the pooled all-country estimates. We
conducted all analyses in CSPro version 4.1.002 and produced
graphics using StataMP 14.3. Results
3.1. Contraceptive prevalence and method mix among 43
countries assessed
Among the 43 countries assessed, overall contraceptive
prevalence ranged from 13% in Senegal to 79% in Vietnam
(Fig. 1). Contraceptive prevalence was extremely low in
Western Africa (range: 13–19%) and low in Eastern Africa
(14–58%). Prevalence was higher in Eastern Europe and
Central Asia (28–69%) and Southern Asia (35–61%), while
LAC (38–77%), Southeastern Asia (range: 49–79%) and
Northern Africa and Western Asia (range: 51–72%) had
the highest contraceptive prevalence. Method mix varied
considerably (Fig. 2).4 We exclude information from the month of interview or the two
preceding months because women in their first trimester may not yet
recognize that they are pregnant, possibly as the result of contraceptive
failure, which would lead to underestimation of failure rates.
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Fig. 1. Current use of modern or traditional contraception among women 15–49, by subregion. Note: E Africa=Eastern Africa. W Africa=Western Africa. N
Afr/W Asia=Northern Africa and Western Asia. E Eur/C Asia=Eastern Europe and Central Asia. S Asia=Southern Asia. SE Asia=Southeastern Asia. We
defined the following to be modern methods: male and female sterilization; implants; IUDs; injectables; oral contraceptive pills; male and female condoms;
diaphragms; foam, jelly and spermicides; Standard Days Method; emergency contraception; fertility wheel calculator; and the Mucus/Billings/Basal body/
Symptothermal method. Not all of these methods were asked about in all surveys. We defined the following to be traditional methods: periodic abstinence;
withdrawal; Lactational Amenorrhea Method (LAM); and other traditional, local or folk methods.
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Fig. 2. Method mix among current contraceptive users 15–49 by subregion.
Note: Subregional estimates are not weighted by country population sizes;
rather, each country within a subregion contributes equally to the
subregional estimate. E Africa=Eastern Africa. W Africa=Western Africa.
N Afr/W Asia=Northern Africa and Western Asia. E Eur/C Asia=Eastern
Europe and Central Asia. S Asia=Southern Asia. SE Asia=Southeastern
Asia. For countries that are included in the distribution for each subregion,
see Fig. 1.
13C.B. Polis et al. / Contraception 94 (2016) 11–173.2. Median method-specific contraceptive failure rates
across all surveys analyzed
Median reported 12-month method-specific contraceptive
failure rates across all included countries are displayed in
Fig. 3. As expected, modern contraceptive methods with the
least room for user error generated the lowest median failure
rates and the lowest variability in these rates. The overall
12-monthmedian failure rate for every 100 episodes ofmethod
use was 0.6 (95% CI: 0.0–2.4) for implants, 1.4 (0.0–2.4) for
IUDs and 1.7 (0.6–2.9) for injectables. Oral contraceptive pills
and condoms had higher failure rates: 5.5 (3.5–7.3) for oral
contraceptive pills and 5.4 (2.3–8.7) for male condoms.
Withdrawal and periodic abstinence had the highest failure
rates: 13.4 (9.1–17.1) for withdrawal and 13.9 (9.2–19.3) for
periodic abstinence. Detailed contraceptive failure rates by
country are available in the full report, and failure rates at 12,
24 and 36 months are provided in Table 1. For implants, IUDs,
pills and periodic abstinence, contraceptive failure generally
decreased with increasing duration (i.e., the 12-month failure
rate was larger than the difference between the 24- and
12-month failure rate, which itself was larger than the
difference between the 36- and 24-month failure rate), while
estimates for injectables, male condoms and withdrawal did
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Fig. 3. Twelve-month typical-use contraceptive failure rate (median) by method. Notes: Median failure rates across all countries contributing data for a give
method were calculated by including estimates from countries with 125 or more unweighted episodes of contraceptive use at life table month 1. Width of box i
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14 C.B. Polis et al. / Contraception 94 (2016) 11–17not demonstrate this pattern. This is likely due to selection of
users at increasing durations of contraceptive use: for example,
women with highest levels of incorrect or inconsistent use
experience failures and therefore are selected out of the
population at risk over time.
3.3. Pooled subregional contraceptive failure rates
Fig. 4 displays pooled subregional 12-month method-
specific failure rate estimates. Women in LAC reported the
highest levels of failure across four out of seven methods
(IUDs, injectables, periodic abstinence and withdrawal).
Twelve-month failure rates across subregions had the
following range of estimates per 100 episodes of use for
each method: implants (0.2–1.3), IUDs (0.9–2.2), injectables
(0.9–4.2), oral contraceptive pills (3.6–8.5), male condoms
(2.2–8.7), withdrawal (7.8–17.1) and periodic abstinence
(6.1–20.9). Specifics by subregion, and for longer durations of
use, are provided in the full report.Table 1
Median cumulative typical-use contraceptive failure rates by method across
43 countries, at 12, 24 and 36 months
12 months 24 months 36 months
Implant 0.6 1.0 1.1
IUD 1.4 1.9 2.1
Injectable 1.7 3.6 5.5
Pill 5.5 10.8 15.1
Male condom 5.4 13.3 16.0
Withdrawal 13.4 27.4 35.7
Periodic abstinence 13.9 25.8 32.4n
s
d3.4. Twelve-month contraceptive failure rates by demographic
and socioeconomic characteristics
We assessed differences in contraceptive failure rates by
age, marital status, parity, contraceptive intention, wealth,
residence and education; complete results for each factor are
detailed in the full Guttmacher report. Of all characteristics
assessed, agewas associatedwith the largest differences in rates
(Fig. 5). For all methods except implants (for which the failure
rate did not vary by age), 12-month contraceptive failure rates
were significantly higher amongwomen younger than 25 years
as compared with their older counterparts. The absolute
differential in 12-month contraceptive failure rates by age
was N10 percentage points among users of traditional methods
such aswithdrawal or periodic abstinence, although the relative
difference was largest for IUD users, with younger IUD users
2.8 times as likely to report a contraceptive failure as older IUD
users. Declines in fecundability and increasing experience in
use of particularmethods that are associatedwith increasing age
may contribute to these observed patterns in failure rates.
Inclusionof unmarriedwomen in this analysis also permitted an
assessment of differences by marital status: we found that
ever-marriedwomen reported similar or lower 12-month failure
rates than never-married women, except among condom users,
among whom this pattern was reversed (Fig. 6).4. Discussion
Reported 12-month failure rates were lowest for users of
longer-acting methods such as implants, IUDs and injectables;
Fig. 4. Twelve-month typical-use contraceptive failure rates and overall median (pooled estimates) by method and subregion. Notes: The implant estimate
for Northern Africa and Western Asia is based on fewer than 250 unweighted episodes of implant use at month 1 (all occurring in Egypt or Jordan), so it should
be interpreted with caution. The implant estimate in Eastern Europe and Central Asia is not reported because of insufficient episodes of implant use (n=6 at
month 1) for estimation. Vertical red line indicates 12-month median estimates displayed in Fig. 3.E Africa=Eastern Africa. W Africa=Western Africa. N Afr/W
Asia=Northern Africa and Western Asia. E Eur/C Asia=Eastern Europe and Central Asia. S Asia=Southern Asia. SE Asia=Southeastern Asia.
15C.B. Polis et al. / Contraception 94 (2016) 11–17intermediate for short-term resupply methods such as oral
contraceptive pills and male condoms; and highest for users of
traditional methods such as withdrawal or periodic abstinence
(largely calendar rhythm). Implant users were 9 times less
likely to report contraceptive failure than women using
contraceptive pills and 23 times less likely than women
using periodic abstinence.
Our estimates for IUDs, injectables and oral contraceptive
pills were similar to a recent large-scale analysis of
contraceptive failure in DHS data by Ali et al. (Table 2)8.3
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Fig. 5. Twelve-month typical-use contraceptive failure rates by age and
method (pooled estimates). Note: Age was measured at the end of the
episode of use.[5]. For condoms, withdrawal and periodic abstinence, our
estimates were somewhat lower, although estimates from Ali
et al. for each of these methods were within the range of the
95% CIs around our estimates, suggesting no statistically
significant differences. Comparing our results to estimates
for the United States is more complicated. Our estimates
were somewhat higher than U.S. estimates for implants (0.6
vs. 0.05) and IUDs (1.4 vs. 0.8), which are derived from
clinical data [11]. U.S. estimates for both of these methods
fall within the 95% CIs for our estimates. On the other hand,
our estimates were markedly lower than U.S. estimates for
injectables (1.7 vs. 6), oral contraceptive pills (5.5 vs. 9),
male condoms (5.4 vs. 18), withdrawal (13.4 vs. 22) and
periodic abstinence (13.9 vs. 24), which are derived from
1995 and 2002 National Surveys of Family Growth and,
notably, are corrected for abortion underreporting.
In general (and aside from estimates from West Africa,
where we had particular concerns about data quality), we
generally observed the lowest method-specific contraceptive
failure rates, in Eastern Africa and Southern Asia. Overall
contraceptive prevalence is low in Eastern Africa and
moderate in Southern Asia, and contraceptive method mix
differs: injectables and pills predominate in Eastern Africa,
while Southern Asia has a substantial amount of female
sterilization and a mix of other methods.
4.1. Limitations
We calculated failure rates based on self-reported informa-
tion (such as contraceptive use and contraceptive failures),
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Fig. 6. Twelve-month typical-use contraceptive failure rates by marital status
and method (pooled estimates). Note: Marital status was measured at the end
of the episode of use.
16 C.B. Polis et al. / Contraception 94 (2016) 11–17which is subject to recall and other biases. Episodes of use of
longer-term methods may be easier to recall and thus better
reported than shorter-term methods [7]. In calendar data,
underreporting of certain methods (particularly condoms and
other short-term modern methods, as well as traditional
methods) in certain countries (particularly in Western Africa
but also other countries in sub-Saharan Africa and Asia) has
been shown [10]. Misclassification of contraceptive failure
(e.g., reporting a contraceptive failure as a deliberate
discontinuation of contraception) or underreporting of contra-
ceptive failure (e.g., to avoid reporting an unintended
pregnancy that led to an abortion due to social desirability
bias) would also impact contraceptive failure rates. National
failure rates estimates for the United States in 2002 indicateTable 2
Comparison of 12-month failure rates in current study, a study using data from 19
Median 12-month failu
Current studyb
Implant 0.6 (0.0–2.4)
IUD 1.4 (0.0–2.4)
Injectable 1.7 (0.6–2.9)
Pill 5.5 (3.5–7.3)
Male condom 5.4 (2.3–8.7)
Withdrawal 13.4 (9.1–17.1)
Periodic abstinence (largely calendar rhythm) 13.9 (9.2–19.3)
a Number of failures per 100 episodes of use.
b Median confidence intervals (CIs) are calculated as a median of all CIs.
c No clinical study has reported an Implanon failure, but pregnancies during it
this implant were arbitrarily set at 0.05; 95% CIs were not provided [11].
d Estimate derived from 1979 study of 3536 women using the TCu 380 A IUD
women accepting the TCu 380 A IUD (0.8) and the associated standard error (0.2
e Weighted averages of estimates derived from the 1995 and 2002 National Sur
not provided [11].
f The overwhelming majority of women using fertility awareness-based metho
this could also include women using newer FABM methods such as Standard D
(when available). na=not available (method was not assessed). COC=combined othat the effect of adjusting for underreporting of abortions
varied bymethod type [12]. It had less of an impact on rates for
oral contraceptive pills, injectables or withdrawal (producing
less than a one-percentage point change in the failure rate, with
inconsistent directionality) and a stronger impact on increasing
failure rates for condoms (from 13.9 to 17.4) and fertility-
awareness-based methods (from 23.0 to 25.3). We are unable
to estimate the impact that omission, misreporting and
underreporting of contraceptive use episodes; reasons for
discontinuation; and abortions resulting from contraceptive
failure may have on failure rates, particularly since the level of
underreporting may vary across surveys. Therefore, the
estimates presented should be viewed as direct reflections of
women's reports, which are potentially affected by a number of
biases. Furthermore, there is need for more recent data in
particular regions, such as LAC. These limitations point toward
potential directions for improving data collection and analytic
approaches that could enhance accurate estimation of contra-
ceptive failure rates in DHS data. It may also be useful to assess
characteristics related to contraceptive failure usingmultivariate
analysis, which was beyond the scope of this work.5. Conclusions
Availability of a range of contraceptive methods is an
essential first step to enable women and couples to select the
most effective method that they prefer to use. Provision of
clear information about the risks and benefits of all available
methods is also crucial in facilitating informed contraceptive
choice. This analysis focused on method-specific typical-use
contraceptive failure rates and demonstrated the lowestDHS surveys and data from the United States
re ratea (95% CI)
Study of
Ali et al. [5]
12-month typical-use failure ratea estimated
from U.S. data (95% CI) [11]
na 0.05 (Implanon)c
1.1 0.8 (0.4–1.2) (ParaGard)d
1.5 6 (Depo-Provera)e
5.6 9 (COC, POP)e
7.6 18e
15.3 22e
17.4 24e (largely calendar rhythm)f
s use have been reported; thus, typical-use (and perfect-use) failure rates for
[14]; 95% CI calculated from 1-year gross cumulative pregnancy rate per 100
) provided in Table 8 of the study by Sivin and Stern [14].
veys of Family Growth, corrected for abortion underreporting; 95% CIs were
ds (FABMs) in the NSFG are believed to be using calendar rhythm, although
ays, TwoDay, Ovulation or Symptothermal. Notes: CI=confidence interval
ral contraceptive pill. POP=progestin-only pill.
17C.B. Polis et al. / Contraception 94 (2016) 11–17failure rates among longer-acting methods. Improving access
to a range of contraceptive options, including long-acting
methods, may help to reduce contraceptive failure and
unintended pregnancy, particularly in subregions where
access to these methods is currently limited, or among
groups with high failure rates for user-dependent methods
(e.g., young women). Especially in areas with high HIV
prevalence, counseling and services should consider the need
for HIV prevention strategies in conjunction with contracep-
tive services. Provision of adequate information, counseling
services and follow-up care may help to improve correctness
and consistency of use and to facilitate switching to preferred
methods and may also help to reduce discontinuation due to
contraceptive failure for all methods. While our analysis did
not assess contraceptive discontinuation for reasons other than
contraceptive failure, discontinuation for reasons such as
health concerns or side effects has been found to be high [5,13]
and should also be addressed through counseling and services
to facilitate switching methods. It may be particularly helpful
to ensure that individuals initiating a contraceptive method are
well-supported to establish effective patterns of use at early
stages of use, which would have the benefit of reducing the
probability of method failures over the long term.
Our results help us to highlight methods, subregions and
population groups that may be in need of particular attention for
decreasing contraceptive failure rates. For example, in subre-
gions like Northern Africa and Western Asia, failure rates are
generally higher than elsewhere, contraceptive prevalence is
moderate to high and method mix is comprised of a substantial
amount of traditional method use. Similarly, younger women
reported higher failure rates than their older counterparts and
are therefore in greater need of improved services and
information. Increased availability and better quality of
counseling and services that meets their need for confiden-
tiality and nonjudgmental care may assist young women in
successfully using their chosen contraceptive method.
This analysis provides a comprehensive assessment of
failure rates across a large range of countries, according to
duration of method use (12, 24 and 36 months), using largely
recently collected data and, where possible, including both
married and unmarried women. Pooling data permitted
estimation of rates for subregions and population subgroups.
This information can be leveraged to better assist women and
couples to avoid unintended pregnancies and to have the
number of children they desire at the time(s) that they feel
ready and able to do so.Acknowledgements
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